Home / Inspections / 1110324

FDA Inspection 1110324 — Aysha E. Badat, MD

Aysha E. Badat, MD — FEI 3015452516

The FDA completed an inspection of Aysha E. Badat, MD on October 21, 2019 in Johannesburg. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 21, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Johannesburg (South Africa)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources